Empatica
Empatica

News

Empatica integrates Mobilise-D Mobility Outcomes into offering

FDA CLEARED

Clinical-quality data from everyday life

The FDA-cleared Empatica Health Monitoring Platform provides accurate, continuous health insights for researchers and clinicians, collected in the real world

Bristol Myers
Regeneron
Novartis
Chugai
Lilly
Bristol Myers
Regeneron
Novartis
Chugai
Lilly

Leading innovation in digital biomarkers

Pioneering digital biomarker development for over a decade, including the first FDA-cleared digital biomarker in neurology, Empatica is dedicated to providing the largest selection of clinically-validated and research-grade digital biomarkers in the world.

Empatica Care
EmbracePlus

An end-to-end remote monitoring solution for clinical trials

The Empatica Health Monitoring Platform is applicable and scalable to countless therapeutic areas. Collect and monitor raw data and digital biomarkers across all phases of your trials using FDA-cleared, award-winning medical technology, alongside a powerful and intuitive software suite.

5

FDA clearances

We have a track-record in producing the highest quality of medical devices

160+

countries available

Our products are currently available in over 20 languages and can be shipped globally. Local regulations may apply

100,000+

devices deployed

From patients to trial participants, Empatica's products have touched thousands of lives

200+

digital measures

The largest range of digital measures in a single solution. Already being used in hundreds of studies

12,000+

research papers

Empatica's technology has been referenced or used to publish thousands of academic papers

Redefining clinical research through medical wearables and digital biomarkers

Our FDA-cleared health monitoring tools are designed to seamlessly collect and monitor health data from daily life. Empatica provides the world’s largest selection of digital measures from a single, versatile wearable, taking gold-standard health measurements from the clinic to the comfort of people’s homes.


More than half of the top 20 pharmaceutical companies use the Empatica Health Monitoring Platform to monitor the impact of treatments and to develop novel digital biomarkers that can be used as digital endpoints. Talk to our team to see how your research can benefit.

Empatica

Latest news and insights

Discover key insights, research, and latest news from across the industry

Get the latest from Empatica delivered directly

Still have questions?

Wondering how our platform can support your remote health monitoring and data collection needs?